This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Micareo Taiwan Co., Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations by Wen-Feng Chung
Wen-Feng Chung is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of microfluidics, particularly with his innovative designs that enhance cell enrichment processes. His work is characterized by a focus on creating efficient and effective solutions for biological applications.
Latest Patents
Wen-Feng Chung holds a patent for a microfluidic chip, which includes an apparatus for enriching cells and a method for enriching cells in a microfluidic chip. This invention features a microfluidic chip that comprises a first and a second cell enrichment system. The channel layouts of these systems are symmetric with respect to a reflection plane that is vertical to the microfluidic chip. Each system includes a first fluid channel, a second fluid channel, a sample channel, an inlet channel, and a filtration chamber. The design allows for precise control over the cell enrichment process, making it a valuable tool in various biological and medical applications. He has 1 patent to his name.
Career Highlights
Wen-Feng Chung is currently employed at Micareo Taiwan Co., Ltd., where he continues to develop innovative technologies in the field of microfluidics. His work has garnered attention for its potential applications in medical diagnostics and research.
Collaborations
Wen-Feng Chung collaborates with talented individuals such as Hui-Min Yu and Jui-Lin Chen, who contribute to the advancement of their projects and research initiatives.
Conclusion
Wen-Feng Chung's contributions to microfluidics exemplify the innovative spirit of modern inventors. His patented microfluidic chip represents a significant advancement in cell enrichment technology, showcasing his commitment to improving scientific research and medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile